The top most factor causing the growth of the hospital acquired infection market is the growing geriatric population across the globe. The geriatric population base is more prone to infections owing to their low physical immunity. Infections, especially nosocomial ones are becoming increasingly common among the elderly. The low level of hygiene maintained by hospitals, poor infrastructure management, and poor sterilizing techniques used at healthcare institutions are resulting in a high number of hospital acquired infection cases. This environment bodes well for the hospital acquired infection market and thus, the market is flourishing. According to the expert panel of analysts at Transparency Market Research (TMR), the global hospital acquired infection market is expected to rise from US$28.99 bn in 2015 to US$36.61 bn by 2024. The market is expected to display a modest CAGR of 2.7% between 2016 and 2024
- Advertising -
The global hospital acquired infection treatment market in 2015 was dominated by a handful of players, including Abbott, Pfizer, Inc., Merck & Co., Inc., and Bayer AG. The market is currently in a state of battle with the growing count of generics available in the world, owing to an incoming wave of patent expirations.
This could create a problem for players trying to maintain favorable profit margins.
View Report at www.transparencymarketresearch.com…tment-market.html
According to a research report released by Transparency Market Research, the highly fragmented global hospital acquired infection treatment market holds a medium level of competition for players of all sizes.
- Advertising -
At the same time, the threat of new entrants to the existing market is very high, owing to the growing demand for enhanced therapeutics, despite the high entry barriers set by strict regulatory frameworks and capital intensive research and development. The global hospital acquired infection treatment market was valued at US$28.99 bn at the end of 2015 and is expected to expand at a CAGR of 2.7% within a forecast period from 2016 to 2024.
By the end of 2024, this market is expected to reach an estimated US$36.61 bn.
Growing Geriatric Population Propels Nosocomial Treatment Demand in Developed Economies
“There is a multi-tracked set of drivers that are currently augmenting the global hospital acquired infection treatment market. Each driver is directly or indirectly linked to the other.
Of the many factors in favor of the market’s growth, the leading factor has to be the growing geriatric population. The elderly – due to their lower physical immunity – are incredibly prone to infections and especially nosocomial ones.
Therefore, the growing population of the geriatric is a serious factor that needs to be accounted for within the global hospital acquired infection treatment market,” states a TMR analyst.
Other factors driving the global hospital acquired infection treatment market include the overall condition of healthcare organizations in emerging economies. Their generally lower levels of hygiene, infrastructure maintenance and sterilization techniques are creating a very high demand for nosocomial infection treatments.
Countries from Asia Pacific, for instance, are currently showing to be leading in terms of growth rate of demand, thereby attracting several prominent players in the global hospital acquired infection treatment market.
Multi-drug Resistant Bacteria Complicating Market Scenario in Nosocomial Infections Treatments
A key restraint acting on the global hospital acquired infection treatment market currently, is the steady increase in the rate of failures in treatment caused by the growing number of multi-drug resistant bacteria. Given a frequent rate of survival of bacteria after being exposed to drugs that are designed to eliminate them, they are known to develop resistance to them, pressuring the healthcare industry to seek alternative treatments or other forms of drug treatments.
There is a growing rate of multi-drug resistant bacteria affecting patients and these infections can prove to be heavily detrimental to a patient’s recovery cycle or even be fatal for them.
Get accurate market forecast and analysis on the Hospital Acquired Infection Treatment Market. Request a sample to stay abreast on the key trends impacting this market.
“Key players in the global hospital acquired infection treatment market are more likely to have multiple drugs in the pipeline, the approval of which can be a shot in the arm for the market. The focus on HAIs is increasing at a fast rate in emerging economies as well, giving rise to a massive untapped market for patients from the lower and middle income classes.
These avenues can prove to be fruitful for players currently established in the global hospital acquired infection treatment market, as well as new entrants in emerging economies,” adds the analyst.
The information presented in this review is based on a Transparency Market Research report, titled, “Hospital Acquired Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
Key segments of the Global Hospital Acquired Infection Treatment Market
Global Hospital Acquired Infection Treatment Market, by Infection Type
- Urinary Tract Infections
- Ventilator Associated Pneumonia
- Surgical Site Infections
- Bloodstream Infections
- Other Hospital Infections (Gastrointestinal Infection, ENT Infections, Skin Infection and Bone Infection)
Global Hospital Acquired Infection Treatment Market, by Treatment
- Antibacterial Treatment
- Antiviral Treatment
- Antifungal Treatment
- Amphotericin B
- Other (Antiparasitic, Antiprotozoal and Anti TB Treatment)
Global Hospital Acquired Infection Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
Hospital Infection Therapeutics Market, by Geography
- North America
- Latin America
- Middle East and Africa
Category: Market Research Publishers and RetailersCompany profile: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. We specialize in the following areas: Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...
For more information: